{"data":{"id":"us/21-cfr-640.50","jurisdiction":"us","citation":"21 CFR 640.50","heading":"Cryoprecipitated AHF.","body":"(a) Proper name and definition. The proper name of this product shall be Cryoprecipitated AHF. The product is defined as a preparation of antihemophilic factor, which is obtained from a single unit of plasma collected and processed in a closed system.\n(b) Source. The source material for Cryoprecipitated AHF shall be plasma which may be obtained by whole blood collection or by plasmapheresis.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER F—BIOLOGICS","PART 640—ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS","Subpart F—Cryoprecipitate"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"bb94717e0eb9eccfca8ddc2e4b675d4bcfbd5e40af826fee9a4e02da197b9e66","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-640.34","next":"us/21-cfr-640.51"},"notice":"GroundRules: Original legal text. Not legal advice."}